Ferring’s Rekovelle has been approved by European regulators for controlled ovarian stimulation in women undergoing assisted reproductive technologies.
Eight medicines have taken a big leap towards being approved in Europe having won the support of the European Medicines Agency’s Committee for Medicinal Products for Human Use.